diphenyleneiodonium has been researched along with Diabetic Nephropathies in 1 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoo, CW | 1 |
| Song, CY | 1 |
| Kim, BC | 1 |
| Hong, HK | 1 |
| Lee, HS | 1 |
1 other study available for diphenyleneiodonium and Diabetic Nephropathies
| Article | Year |
|---|---|
Glycated albumin induces superoxide generation in mesangial cells.
Topics: Cells, Cultured; Diabetic Nephropathies; Glomerular Mesangium; Glycated Serum Albumin; Glycation End | 2004 |